Member News

Gokhale named biotech secretary; Wecewicz receives alumni award

ASBMB Today Staff
Dec. 13, 2021

Gokhale takes over as government biotechnology secretary

Rajesh Gokhale, who studies tuberculosis at India's National Institute of Immunology in New Delhi, has been appointed the secretary of the Indian Department of Biotechnology. He started in this new position on November 1.

Rajesh Gokhale

The Department of Biotechnology, part of the ministry of science and technology, funds scholarships, research awards and scientific training efforts; coordinates large studies such as cataloging genetic variation in India; administers core facilities for advanced imaging, electron microscopy and mass spectrometry; and supports independent research institutes with a variety of focus areas. As the department’s secretary, Gokhale will be second in command to biotechnology minister Jitendra Singh, who reports to the prime minister of India.

Gokhale's research focuses on mycobacterium tuberculosis, the pathogen that causes tuberculosis, and its metabolism. He studies polyketide synthases, which generate a wide variety of metabolites that contribute to pathogenicity. He also has studied skin pigmentation, contributing to scientific understanding of the autoimmune disorder vitiligo.

Gokhale is a past member of the editorial board of the Journal of Biological Chemistry and a former Howard Hughes Medical Institute international scholar. In addition to other honors, he is a fellow of the Indian National Science Academy, the National Academy of Sciences India and the India Academy of Sciences.

Young alumni award for Wencewicz

Timothy Wencewicz, an associate professor at Washington University in St. Louis, received the Southeast Missouri State University Alumni Association's Distinguished Young Alumni award in October. 

Timothy Wencewicz

Wencewicz studies antimicrobial resistance, including investigations into the microbial enzymes that break down and inactivate currently available antibiotics. He has studied new potential antimicrobial delivery systems, such as conjugating an antimicrobial agent to a siderophore, a type of iron-conjugating molecule that many microbes use to scavenge iron from the environment, to sneak the antimicrobial molecule into the cell. 

After he attended Southeast Missouri State University as an undergraduate, Wencewicz earned his Ph.D. in chemistry at the University of Notre Dame and trained as a postdoc at Harvard Medical School. He returned to Missouri in 2013 to join the faculty at Washington University.

Wencewicz serves on the editorial boards of the Journal of Biological Chemistry and the Journal of Antibiotics. In addition to this recent honor, he has received he has received are a Cottrell Scholar Award, a Camille Dreyfus Teacher–Scholar Award and a Sloan Research Fellowship in chemistry.


 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.